Tenderwize
Retour à la recherche

Discount agreement for Calcipotriol/Betamethasone cream

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen·Erfurt, Germany·Deadline May 31, 2028 · 642 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Calcipotriol/Betamethason - Creme (amtlicher ATC-Code: D05AX22)

30/100

Score d'opportunité

Needs reviewLow complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

30 / 100

Complexité

20 / 100

Facteurs de risque

No guaranteed purchase quantities; actual demand is uncertain and dependent on physician prescribing and pharmacy prefe...

The authority may terminate the Open-House process early if exclusive discount agreements are concluded, typically with...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until May 2028
  • Supply of Calcipotriol/Betamethasone cream (ATC D05AX22) as a pharmaceutical product
  • Conclusion of non-exclusive discount agreements under § 130a Abs. 8 SGB V
Afficher le résumé complet

This is an Open-House model (non-competitive) for non-exclusive drug discount agreements under § 130a Abs. 8 SGB V for the active substance Calcipotriol/Betamethasone (ATC D05AX22) in cream form. The contracting authority is AOK PLUS for Saxony and Thuringia, Germany. The agreement runs until 31 May 2028, with no guarantee of minimum purchase quantities. The tender is published voluntarily on TED for transparency; it is not a public procurement subject to EU directives. Important: the discount terms are confidential and only accessible after requesting access to the DTVP project room.

Risques

No guaranteed purchase quantities; actual demand is uncertain and dependent on physician prescribing and pharmacy prefe...

The authority may terminate the Open-House process early if exclusive discount agreements are concluded, typically with...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Must be a pharmaceutical entrepreneur as per § 4 Abs. 18 AMG with respect to the offered medicinal product
  • Must have registered seat in Germany, EU, or EEA (§ 9 Abs. 2 AMG)

Eligibility

  • Submit self-declaration on exclusion grounds (§§ 123, 124 GWB)

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

No explicit award criteria provided; the agreement is based on acceptance of the discount terms, not on competitive scoring.

Acheteur

Localisation

Erfurt, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE256878834

Activité

Health

Lots (1)

LOT-0001

Discount agreement for Calcipotriol/Betamethasone cream

Non-exclusive discount agreement for the supply of Calcipotriol/Betamethasone cream. Open to all qualified pharmaceutical entrepreneurs who accept the terms. No individual negotiations; no exclusivity. No guaranteed volumes.

SuppliesFrameworkEU fundedElectronic submission

Localisation

Dresden, Germany

Durée

May 2026 - May 2028

Catégorie

Pharmaceutical products

Critères d'attribution

No explicit award criteria provided; the agreement is based on acceptance of the discount terms, not on competitive scoring.

Date limite

Deadline May 31, 2028

Détails de la procédure

Date de publication
25 Mar 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
207477-2026

Documents (1)

Document de consultation 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30